Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery

NCT06196684 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-10-06

No results posted yet for this study

Summary

The aim of the study is to evaluate early safety and clinical efficacy of mitral allografts in tricuspid valve replacement for primary tricuspid valve diseases.

Conditions

  • Allografts
  • Tricuspid Valve Insufficiency

Interventions

PROCEDURE

Mitral allograft implantation

Tricuspid valve replacement with mitral valve allograft

Sponsors & Collaborators

  • Chelyabinsk Regional Clinical Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2026-09-29
Completion
2026-10-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06196684 on ClinicalTrials.gov